GAINESVILLE, Fla. — Two days after leading the Florida basketball team to a dramatic last-second win at Missouri, senior point guard Chris Chiozza was diagnosed with strep throat, putting his status for the Gators’ game Wednesday night against Mississippi State in jeopardy.
Chiozza won’t practice Monday or Tuesday and the team remains hopeful he’ll be able to play against the Bulldogs, but it could come down to a game day decision.
Florida coach Mike White had already finished speaking with reporters Monday morning, lauding Chiozza’s play, when word came out from the team’s medical staff. Chiozza had been scheduled to speak with the media as well, but he was not feeling well and proceeded to meet with the trainers.
Chiozza has been the leader of this Florida team, helping the Gators (11-4) to a 3-0 start in SEC play, including his clutch performance Saturday when he stole a pass with the clock ticking down and raced for the game-winning layup before the buzzer in a 77-75 win at Missouri.
“Right when he made the steal, I remember looking up at the clock immediately and thinking, ‘Yeah, he’s got time.’ And then I thought, ‘Boy, I love Chris Chiozza. I’m glad he’s on my team,'” White said.
Chiozza ranks third on the Gators in scoring at 13.1 points per game while also averaging 5.8 assists in a team-high 31.7 minutes per contest.
If he can’t play Wednesday night, junior guard KeVaughn Allen would likely take a large share of the point guard responsibilities while freshman Mike Okauru would probably see more playing time.
Mississippi State visits with a 13-2 overall record and 1-1 mark in the SEC.
The post Florida basketball: Chris Chiozza’s status in doubt for Mississippi State game due to strep throat appeared first on SEC Country.
Thank you for reading the Dayton Daily News and for supporting local journalism. Subscribers: log in for access to your daily ePaper and premium newsletters.
Thank you for supporting in-depth local journalism with your subscription to the Dayton Daily News. Get more news when you want it with email newsletters just for subscribers. Sign up here.